JPL Wealth Management’s Haemonetics HAE Stock Holding History

JPL Wealth Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375	Hold	5	–	–	﹤0.01%	1436
2026 Q1	$282	Buy	+5	New	+$326	﹤0.01%	1373
2025 Q4	–	Sell	-5	Closed	-$244	–	535
2025 Q3	$244	Buy	+5	New	+$309	﹤0.01%	1132

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JPL Wealth Management's HAE Position: Q2 2026 in Review

JPL Wealth Management held its Haemonetics (HAE) position steady in Q2 2026 at 5 shares worth $375. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

JPL Wealth Management first reported a position in HAE in Q3 2025 and has held it in 3 quarters since. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

JPL Wealth Management held 5 shares of Haemonetics worth $375 as of Q2 2026.
JPL Wealth Management left its Haemonetics share count unchanged in Q2 2026.
Haemonetics made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1436 holding.
JPL Wealth Management first reported a position in Haemonetics in Q3 2025 and has held it in 3 quarters since.
330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.